Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Visceral Metastatic Disease
Abstract
Authors
A. Valderrama S.P. Bilir E.A. Wehler B.S. Seal L. Wen A. Yaldo J. Munakata